ResearchIn-Press PreviewHematologyImmunology Open Access | 10.1172/jci.insight.181063
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Cantrell, R. in: JCI | PubMed | Google Scholar
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Feldman, H. in: JCI | PubMed | Google Scholar |
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Rosenfeldt, L. in: JCI | PubMed | Google Scholar
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Ali, A. in: JCI | PubMed | Google Scholar |
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Gourley, B. in: JCI | PubMed | Google Scholar
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Sprague, C. in: JCI | PubMed | Google Scholar
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Leino, D. in: JCI | PubMed | Google Scholar
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Crosby, J. in: JCI | PubMed | Google Scholar
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Revenko, A. in: JCI | PubMed | Google Scholar |
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Monia, B. in: JCI | PubMed | Google Scholar
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Waggoner, S. in: JCI | PubMed | Google Scholar |
1Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
2Center for Autoimmune Genomics and Etiology, Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
3Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
4Antisense Drug Discovery, Ionis Pharmaceuticals, Carlsbad, United States of America
Find articles by Palumbo, J. in: JCI | PubMed | Google Scholar
Published January 16, 2025 - More info
Thrombin promotes the proliferation and function of CD8+ T cells. To test if thrombin prevents exhaustion and sustains antiviral T cell activity during chronic viral infection, we depleted the thrombin-precursor prothrombin to 10% of normal levels in mice prior to infection with the clone 13 strain of lymphocytic choriomeningitis virus. Unexpectedly, prothrombin insufficiency resulted in 100% mortality after infection that was prevented by depletion of CD8+ T cells, suggesting that reduced availability of prothrombin enhances virus-induced immunopathology. Yet, the number, function, and apparent exhaustion of virus-specific T cells were measurably unaffected by prothrombin depletion. Histological analysis of the lung, heart, liver, kidney, spleen, intestine, and brain did not reveal any evidence of hemorrhage or increased tissue damage in low prothrombin mice that could explain mortality. Viral loads were also similar in infected mice regardless of prothrombin levels. Instead, infection of prothrombin-depleted mice resulted in a severe, T cell-dependent anemia associated with increased hemolysis. Thus, thrombin plays an unexpected protective role in preventing hemolytic anemia during virus infection, with potential implications for patients who are using direct thrombin inhibitors as an anticoagulant therapy.